Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Lead Time and Tailored Messaging Promote Early-Onset Colorectal Cancer Prevention and Screening.

Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2026
Same author

Advancing disability inclusion in nursing education: A call for national data collection and collective leadership.

Journal of professional nursing : official journal of the American Association of Colleges of Nursing·2025
Same author

Efimosfermin alfa (BOS-580), a long-acting FGF21 analogue, in participants with phenotypic metabolic dysfunction-associated steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial.

The lancet. Gastroenterology & hepatology·2025
Same author

Disability and Accommodation Use in US Bachelor of Science in Nursing Programs.

JAMA network open·2025
Same author

Obesity and GLP-1s.

Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2025
Same author

Spread the Word: No Amount of Alcohol is Safe!

Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2024

相关实验视频

Updated: Jul 26, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

716

腺瘤检测率基准:一个更新的分析.

Linda Morrow1,2, Beverly Greenwald1,2

  • 1Linda Morrow, DNP, MSN, MBA, NE-BC, CPHQ, CNOR, RN, is Program Director, Nursing Management and Executive Leadership, Clinical Associate Professor of Nursing, Dr. Susan L. Davis & Richard J. Henley College of Nursing, Sacred Heart University, Fairfield, Connecticut.

Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates
|June 14, 2023
PubMed
概括

现在推的结直肠癌查年龄是45岁,影响了腺瘤检测率基准. 目前的基准可以应用于年轻的患者,但可能需要性别特定的比率.

更多相关视频

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:08

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

110
Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
05:49

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

6.6K

相关实验视频

Last Updated: Jul 26, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

716
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:08

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

110
Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
05:49

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

6.6K

科学领域:

  • 胃肠病学 胃肠病学
  • 结肠直肠癌查 结肠直肠癌查
  • 内镜质量指标的使用方法

背景情况:

  • 早发性结肠直肠癌导致查年龄从50岁降低到45岁.
  • 美国胃肠内镜学会建议对结肠镜进行质量指标.
  • 腺瘤检测率 (ADR) 是一个关键的质量指标,为50岁以上的患者建立了基准.

研究的目的:

  • 评估新查年龄对腺瘤检测率基准的影响.
  • 为了确定当前的基准是否适用于45-50岁的年龄组.
  • 探索腺瘤检测率的潜在基于性别的差异.

主要方法:

  • 对五项检查腺瘤检测率的研究进行了综述.
  • 分析数据,包括45-50岁的患者.
  • 组合和性别特异性腺瘤检测率的比较.

主要成果:

  • 在使用现有基准 (25%的组合,或20%的女性/30%的男性分别) 的ADR计算中应包括45-50岁的患者.
  • 在分离性别的研究中,男性的腺瘤患病率始终高于女性.
  • 一项研究表明,基于性别的单独基准可能是合理的.

结论:

  • 目前的腺瘤检测率基准可适应45-50岁年龄组.
  • 性别特定的腺瘤检测率可能会改善某些实践中的质量评估.
  • 需要进一步的研究来完善查质量指标,以适应不断变化的结直肠癌查指南.